Cargando…

Prescription ω−3 Therapy to Reduce Triglyceride Levels—A New Horizon for Cost-effective Therapy

Detalles Bibliográficos
Autor principal:	Mozaffarian, Dariush
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413389/ https://www.ncbi.nlm.nih.gov/pubmed/35157063 http://dx.doi.org/10.1001/jamanetworkopen.2021.48191

Ejemplares similares

New Horizons in Antifungal Therapy
por: Pianalto, Kaila M., et al.
Publicado: (2016)

Effectiveness of a Novel ω-3 Krill Oil Agent in Patients With Severe Hypertriglyceridemia: A Randomized Clinical Trial
por: Mozaffarian, Dariush, et al.
Publicado: (2022)

Challenges in Treating Genodermatoses: New Therapies at the Horizon
por: Morren, Marie-Anne, et al.
Publicado: (2022)

Goal-Directed Therapy: New Trends and Horizons
por: Kirov, Mikhail, et al.
Publicado: (2012)

New medical therapies on the horizon: oral octreotide
por: Biermasz, Nienke R.
Publicado: (2017)

New Horizons: Novel Adrenal Regenerative Therapies
por: Bornstein, Stefan R, et al.
Publicado: (2020)

New landscapes and horizons in hepatocellular carcinoma therapy
por: Cervello, Melchiorre, et al.
Publicado: (2020)

New horizons in pulmonary arterial hypertension therapies
por: Galiè, Nazzareno, et al.
Publicado: (2013)

Personalized medicine: a new horizon for medical therapy
por: Weissman, Sherman Morton
Publicado: (2018)

Modelling the potential cost-effectiveness of food-based programs to reduce malnutrition
por: Webb, Patrick, et al.
Publicado: (2021)

News on the horizon in glioblastoma therapy
por: Herrlinger, Ulrich
Publicado: (2020)

ω3 Polyunsaturated Fatty Acids as Immunomodulators in Colorectal Cancer: New Potential Role in Adjuvant Therapies
por: Miccadei, Stefania, et al.
Publicado: (2016)

ω-3 oil intake during weight loss in obese women results in remodelling of plasma triglyceride and fatty acids
por: McCombie, Gregor, et al.
Publicado: (2009)

PUFA ω-3 and ω-6 biomarkers and sleep: a pooled analysis of cohort studies on behalf of the Fatty Acids and Outcomes Research Consortium (FORCE)
por: Murphy, Rachel A, et al.
Publicado: (2021)

aHUS caused by complement dysregulation: new therapies on the horizon
por: Waters, Aoife M., et al.
Publicado: (2010)

Hope on the Horizon: New and Future Therapies for Sickle Cell Disease
por: Kuriri, Fahd A.
Publicado: (2023)

ω-3 and ω-6 Polyunsaturated Fatty Acids, Obesity and Cancer
por: D’Angelo, Stefania, et al.
Publicado: (2020)

Anti-VEGF therapy as adjuvant therapy: clouds on the horizon?
por: Schneider, Bryan P, et al.
Publicado: (2009)

Soyasapogenols reduce cellular triglyceride levels in 3T3-L1 mouse adipocyte cells by accelerating triglyceride lipolysis
por: Iwamoto, Kazuko, et al.
Publicado: (2018)

Bronchial asthma: is personalized therapy on the horizon?
por: Taube, Christian
Publicado: (2014)

Hepatocellular carcinoma, novel therapies on the horizon
por: El Dika, Imane, et al.
Publicado: (2020)

Where art meets neuroscience: a new horizon of art therapy
por: Konopka, Lukasz M.
Publicado: (2014)

Erratum to: aHUS caused by complement dysregulation: new therapies on the horizon
por: Waters, Aoife M., et al.
Publicado: (2012)

Therapy of Patients with Neuroendocrine Neoplasia—Evidence-Based Approaches and New Horizons
por: Bundschuh, Ralph A., et al.
Publicado: (2019)

Apple Vision Pro: a new horizon in psychological research and therapy
por: Zhang, Zhihui, et al.
Publicado: (2023)

Transgenic conversion of ω-6 to ω-3 polyunsaturated fatty acids via fat-1 reduces the severity of post-traumatic osteoarthritis
por: Kimmerling, Kelly A., et al.
Publicado: (2020)

HORIZON I: Is there a future for oral anti-angiogenics on the horizon of colorectal cancer therapy?
por: Hochster, H S
Publicado: (2013)

New Horizons.
Publicado: (1876)

New Horizons
por: Dogra, Vikram
Publicado: (2011)

Increased ω6-Containing Phospholipids and Primary ω6 Oxidation Products in the Brain Tissue of Rats on an ω3-Deficient Diet
por: Axelsen, Paul H., et al.
Publicado: (2016)

The importance of a balanced ω-6 to ω-3 ratio in the prevention and management of obesity
por: Simopoulos, Artemis P, et al.
Publicado: (2016)

Implications of dietary ω-3 and ω-6 polyunsaturated fatty acids in breast cancer
por: Zanoaga, Oana, et al.
Publicado: (2018)

A Mixture of Polyunsaturated Fatty Acids ω-3 and ω-6 Reduces Melanoma Growth by Inhibiting Inflammatory Mediators in the Murine Tumor Microenvironment
por: Almeida, Ewin B., et al.
Publicado: (2019)

Cognitive Behavioral Therapy for Insomnia Reduces Hypnotic Prescriptions
por: Park, Kyung Mee, et al.
Publicado: (2018)

Updates on Anticancer Therapy-Mediated Vascular Toxicity and New Horizons in Therapeutic Strategies
por: Hsu, Po-Yen, et al.
Publicado: (2021)

Current Treatment Approach, Emerging Therapies and New Horizons in Systemic Lupus Erythematosus
por: Athanassiou, Panagiotis, et al.
Publicado: (2023)

Importance of the Role of ω-3 and ω-6 Polyunsaturated Fatty Acids in the Progression of Brain Cancer
por: Montecillo-Aguado, Mayra, et al.
Publicado: (2020)

Sorghum MSD3 Encodes an ω-3 Fatty Acid Desaturase that Increases Grain Number by Reducing Jasmonic Acid Levels
por: Dampanaboina, Lavanya, et al.
Publicado: (2019)

Do healthier foods and diet patterns cost more than less healthy options? A systematic review and meta-analysis
por: Rao, Mayuree, et al.
Publicado: (2013)

Impact of Out-of-Pocket Costs on Prescription Fills Among New Initiators of Biologic Therapies for Rheumatoid Arthritis
por: Hopson, Sari, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qnqq76kdu4of5nnaru10622bn0